2024
DOI: 10.1001/jamapediatrics.2023.4681
|View full text |Cite
|
Sign up to set email alerts
|

Ethically Advancing Pediatric Cardiac Xenotransplant

Daniel J. Hurst,
Luz Padilla

Abstract: This Viewpoint examines how pediatrics should prepare for the prospect of cardiac xenotransplant, including its ethical implications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…Acceptance also fell (to 35%) even if the xenograft was considered to be a "bridge" to allotransplantation, i.e., a temporary therapy to help a patient survive for a relatively short period of time (weeks or months) until a deceased human organ becomes available. This concept of "bridging" is particularly relevant to babies born with complex congenital heart disease (i.e., born with an abnormal heart structure) for whom no truly successful therapy may be available [22]. In these babies, the transplantation of a human heart (allotransplantation) is followed by very successful outcomes, but it may be several months before a heart from a suitablesized deceased human donor becomes available (during which period the patient may not survive).…”
Section: Review Of Current Public Engagementmentioning
confidence: 99%
See 1 more Smart Citation
“…Acceptance also fell (to 35%) even if the xenograft was considered to be a "bridge" to allotransplantation, i.e., a temporary therapy to help a patient survive for a relatively short period of time (weeks or months) until a deceased human organ becomes available. This concept of "bridging" is particularly relevant to babies born with complex congenital heart disease (i.e., born with an abnormal heart structure) for whom no truly successful therapy may be available [22]. In these babies, the transplantation of a human heart (allotransplantation) is followed by very successful outcomes, but it may be several months before a heart from a suitablesized deceased human donor becomes available (during which period the patient may not survive).…”
Section: Review Of Current Public Engagementmentioning
confidence: 99%
“…This concept of “bridging” is particularly relevant to babies born with complex congenital heart disease (i.e., born with an abnormal heart structure) for whom no truly successful therapy may be available [ 22 ]. In these babies, the transplantation of a human heart (allotransplantation) is followed by very successful outcomes, but it may be several months before a heart from a suitable‐sized deceased human donor becomes available (during which period the patient may not survive).…”
Section: Review Of Current Public Engagementmentioning
confidence: 99%